[18F]FDG uptake of the normal spinal cord in PET/MR imaging: comparison with PET/CT imaging

被引:7
|
作者
Aiello, Marco [1 ]
Alfano, Vincenzo [1 ]
Salvatore, Elena [2 ]
Cavaliere, Carlo [1 ]
Picardi, Marco [3 ]
Della Pepa, Roberta [3 ]
Nicolai, Emanuele [1 ]
Soricelli, Andrea [1 ]
Vella, Alessandra [4 ]
Salvatore, Marco [1 ]
Mascalchi, Mario [5 ]
机构
[1] IRCCS SDN, Naples, Italy
[2] Univ Naples Federico II, Dept Neurosci, Naples, Italy
[3] Dept Clin Med & Surg, Hematol Sect, Naples, Italy
[4] Le Scotte Hosp Siena, Nucl Med, Siena, Italy
[5] Univ Florence, Mario Serio Dept Expt & Clin Biomed Sci, Florence, Italy
关键词
FDG; PET; MRI; Spinal cord; SUV; EMISSION-TOMOGRAPHY; METABOLISM; SUV;
D O I
10.1186/s13550-020-00680-8
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background The lack of visualization of the spinal cord hinders the evaluation of [F-18]Fluoro-deoxy-glucose (FDG) uptake of the spinal cord in PET/CT. By exploiting the capability of MRI to precisely outline the spinal cord, we performed a retrospective study aimed to define normal pattern of spinal cord [F-18]FDG uptake in PET/MRI. Methods Forty-one patients with lymphoma without clinical or MRI signs of spinal cord or bone marrow involvement underwent simultaneous PET and MRI acquisition using Siemens Biograph mMR after injection of 3.5 MBq/kg body weight of [F-18]FDG for staging purposes. Using a custom-made software, we placed ROIs of 3 and 9 mm in diameter in the spinal cord, lumbar CSF, and vertebral marrow that were identified on MRI at 5 levels (C2, C5, T6, T12, and L3). The SUVmax, SUVmean, and the SUVmax and SUVmean normalized (NSUVmax and NSUVmean) to the liver were measured. For comparison, the same ROIs were placed in PET-CT images obtained immediately before the PET-MRI acquisition following the same tracer injection. Results On PET/MRI using the 3 mm ROI, the following average (all level excluding L3) spinal cord median (1st and 3rd quartile) values were measured: SUVmean, 1.68 (1.39 and 1.83); SUVmax, 1.92 (1.60 and 2.14); NSUVmean, 1.18 (0.93 and 1.36); and NSUVmax, 1.27 (1.01 and 1.33). Using the 9 mm ROI, the corresponding values were SUVmean, 1.41 (1.25-1.55); SUVmax, 2.41 (2.08 and 2.61); NSUVmean, 0.93 (0.79 and 1.04); and NSUVmax, 1.28 (1.02 and 1.39). Using the 3 mm ROI, the highest values of PET-MRI SUVmax, SUVmean, NSUVmax, and NSUVmean were consistently observed at C5 and the lowest at T6. Using a 9 mm ROI, the highest values were consistently observed at C5 and the lowest at T12 or T6. The spinal cord [F-18]FDG-uptake values correlated with the bone marrow uptake at the same level, especially in case of NSUVmax. Comparison with PET-CT data revealed that the average SUVmax and SUVmean of the spinal cord were similar in PET-MRI and PET-CT. However, the average NSUVmax and NSUVmean of the spinal cord were higher (range 21-47%) in PET-MRI than in PET-CT. Conclusions Using a whole-body protocol, we defined the maximum and mean [F-18]FDG uptake of the normal spinal cord in PET/MRI. While the observed values show the expected longitudinal distribution, they appear to be higher than those measured in PET/CT. Normalization of the SUVmax and SUVmean of the spinal cord to the liver radiotracer uptake could help in multi-institutional comparisons and studies.
引用
收藏
页数:9
相关论文
共 50 条
  • [11] Can physiologic colonic [18F]FDG uptake in PET/CT imaging predict response to immunotherapy in metastatic melanoma?
    Sachpekidis, Christos
    Stein-Thoeringer, Christoph K. K.
    Kopp-Schneider, Annette
    Weru, Vivienn
    Dimitrakopoulou-Strauss, Antonia
    Hassel, Jessica C. C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (12) : 3709 - 3722
  • [12] [18F]FAPI-42 PET/CT versus [18F]FDG PET/CT for imaging of recurrent or metastatic gastrointestinal stromal tumors
    Wu, Chunhui
    Zhang, Xinhua
    Zeng, Yu
    Wu, Renbo
    Ding, Li
    Xia, Yanzhe
    Chen, Zhifeng
    Zhang, Xiangsong
    Wang, Xiaoyan
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 50 (01) : 194 - 204
  • [13] [18F]FAPI-42 PET/CT versus [18F]FDG PET/CT for imaging of recurrent or metastatic gastrointestinal stromal tumors
    Chunhui Wu
    Xinhua Zhang
    Yu Zeng
    Renbo Wu
    Li Ding
    Yanzhe Xia
    Zhifeng Chen
    Xiangsong Zhang
    Xiaoyan Wang
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 50 : 194 - 204
  • [14] Extended field imaging in 2-[18F]FDG PET/CT in multiple myeloma
    Koc, Zehra Pinar
    Ozcan, Pelin
    Akdeniz, Aydan
    Saglam, Zeynep Selcan
    IRANIAN JOURNAL OF NUCLEAR MEDICINE, 2023, 31 (02): : 167 - 172
  • [15] Comparison of Whole-Body 18F FDG PET/MR Imaging and Whole-Body 18F FDG PET/CT in Terms of Lesion Detection and Radiation Dose in Patients with Breast Cancer
    Melsaether, Amy N.
    Raad, Roy A.
    Pujara, Akshat C.
    Ponzo, Fabio D.
    Pysarenko, Kristine M.
    Jhaveri, Komal
    Babb, James S.
    Sigmund, Eric E.
    Kim, Sungheon G.
    Moy, Linda A.
    RADIOLOGY, 2016, 281 (01) : 193 - 202
  • [16] Imaging of Acquired Demyelinating Syndrome With 18F-FDG PET/CT
    Malo-Pion, Caroline
    Lambert, Raymond
    Decarie, Jean-Claude
    Turpin, Sophie
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (02) : 103 - 105
  • [17] [18F]FDG PET/CT and PET/MR in Patients with Adrenal Lymphoma: A Systematic Review of Literature and a Collection of Cases
    Evangelista, Laura
    Crimi, Filippo
    Visentin, Andrea
    Voltan, Giacomo
    Trentin, Livio
    Lacognata, Carmelo
    Cecchin, Diego
    Ceccato, Filippo
    CURRENT ONCOLOGY, 2022, 29 (10) : 7887 - 7899
  • [18] Standardized uptake values for [18F] FDG in normal organ tissues: Comparison of whole-body PET/CT and PET/MRI
    Heusch, Philipp
    Buchbender, Christian
    Beiderwellen, Karsten
    Nensa, Felix
    Hartung-Knemeyer, Verena
    Lauenstein, Thomas C.
    Bockisch, Andreas
    Forsting, Michael
    Antoch, Gerald
    Heusner, Till A.
    EUROPEAN JOURNAL OF RADIOLOGY, 2013, 82 (05) : 870 - 876
  • [19] PET/CT in patients with hepatocellular carcinoma using [18F]fluorocholine: preliminary comparison with [18F]FDG PET/CT
    Jean-Noël Talbot
    Fabrice Gutman
    Laetitia Fartoux
    Jean-Didier Grange
    Nathalie Ganne
    Khaldoun Kerrou
    Dany Grahek
    Françoise Montravers
    Raoul Poupon
    Olivier Rosmorduc
    European Journal of Nuclear Medicine and Molecular Imaging, 2006, 33 : 1285 - 1289
  • [20] PET/CT in patients with hepatocellular carcinoma using [18F] fluorocholine:: preliminary comparison with [18F]FDG PET/CT
    Talbot, Jean-Noël
    Gutman, Fabrice
    Fartoux, Laetitia
    Grange, Jean-Didier
    Ganne, Nathalie
    Kerrou, Khaldoun
    Grahek, Dany
    Montravers, Francoise
    Poupon, Raoul
    Rosmorduc, Olivier
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 (11) : 1285 - 1289